The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
The Hippo pathway effector YAP controls mouse hepatic stellate cell activation
Abstract
Background & aims Hepatic stellate cell activation is a wound-healing response to liver injury. However, continued activation of stellate cells during chronic liver damage causes excessive matrix deposition and the formation of pathological scar tissue leading to fibrosis and ultimately cirrhosis. The importance of sustained stellate cell activation for this pathological process is well recognized, and several signalling pathways that can promote stellate cell activation have been identified, such as the TGFβ-, PDGF-, and LPS-dependent pathways. However, the mechanisms that trigger and drive the early steps in activation are not well understood. Methods and results We identified the Hippo pathway and its effector YAP as a key pathway that controls stellate cell activation. YAP is a transcriptional co-activator and we found that it drives the earliest changes in gene expression during stellate cell activation. Activation of stellate cells in vivo by CCl4 administration to mice or activation in vitro caused rapid activation of YAP as revealed by its nuclear translocation and by the induction of YAP target genes. YAP was also activated in stellate cells of human fibrotic livers as evidenced by its nuclear localization. Importantly, knockdown of YAP expression or pharmacological inhibition of YAP prevented hepatic stellate cell activation in vitro and pharmacological inhibition of YAP impeded fibrogenesis in mice. Conclusions YAP activation is a critical driver of hepatic stellat…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the liver, HSCs regulate fibrosis through the activation of MRTFA and YAP cofactors, controlling the expression of several profibrotic proteins [17, 18].”
From Mechanical stiffness orchestrates distinct regulation of MRTFs and YAP / TAZ transcriptional cofactors in hepatocytes (2026) · cites this paper as [18]
In the citing paper
“Pharmaceutical inhibition of these cofactors significantly attenuates ECM deposition and the expression of profibrotic regulators [18, 19].”
From Mechanical stiffness orchestrates distinct regulation of MRTFs and YAP / TAZ transcriptional cofactors in hepatocytes (2026) · cites this paper as [18]
In the citing paper
“It has been demonstrated that stiffness regulates the activation of MRTcoF in liver fibrosis; however, their simultaneous regulation has not been characterised entirely [17, 18].”
From Mechanical stiffness orchestrates distinct regulation of MRTFs and YAP / TAZ transcriptional cofactors in hepatocytes (2026) · cites this paper as [18]
Citations
Cites
Role of YAP/TAZ in mechanotransduction
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979
Taking Cell-Matrix Adhesions to the Third Dimension
Cukierman, E., Pankov, R., Stevens, D. R., & Yamada, K. M. (2001) · Science · doi:10.1126/science.1064829 · Cited by 3,027
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Elucidation of a universal size-control mechanism in Drosophila and mammals
Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., & Pan, D. (2007) · Cell · doi:10.1016/j.cell.2007.07.019 · Cited by 2,370
Liu-Chittenden, Y., Huang, B., Shim, J. S., Chen, Q., Lee, S.-J., Anders, R. A., Liu, J. O., & Pan, D. (2012) · Genes & Development · doi:10.1101/gad.192856.112 · Cited by 1,452
Mederacke, I., Hsu, C. C., Troeger, J. S., Huebener, P., Mu, X., Dapito, D. H., Pradere, J.-P., & Schwabe, R. F. (2013) · Nature Communications · doi:10.1038/ncomms3823 · Cited by 1,443
YAP1 increases organ size and expands undifferentiated progenitor cells
Camargo, F. D., Gokhale, S., Johnnidis, J. B., Fu, D., Bell, G. W., Jaenisch, R., & Brummelkamp, T. R. (2007) · Current Biology · doi:10.1016/j.cub.2007.10.039 · Cited by 1,252
The emerging roles of YAP and TAZ in cancer
Moroishi, T., Hansen, C. G., & Guan, K. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3876 · Cited by 1,181
Hippo signaling: growth control and beyond
Halder, G. A., & Johnson, R. L. (2010) · Development · doi:10.1242/dev.045500 · Cited by 1,091
Self-citationZhou, D., Conrad, C. H., Xia, F., Park, J.-S., Payer, B., Yin, Y., Lauwers, G. Y., Thasler, W. E., Lee, J. T., Avruch, J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.026 · Cited by 937
Cited by
Sorted by citations
Items 401–412 of 412
A practical toolbox for modelling fibrosis in vitro
Morsink, M. A. J., Fleischer, S., Nash, T. R., Falcucci, T., Leonard‐Duke, J., Li, V. Y., Pinezich, M. R., Sahoo, J. K., Hasturk, O., Lee, A., et al. (2026) · Nature Biomedical Engineering · doi:10.1038/s41551-026-01749-w
Raj, A., & Kosey, S. (2026) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-026-00644-8
Zhang, C., Zuo, X., Hou, X., Zhang, Y., Sun, R., Pu, Y., & Zhang, J. (2026) · Environmental Chemistry and Ecotoxicology · doi:10.1016/j.enceco.2026.07.013
Hai, H., Mai, J., Wang, J., Zheng, G., & Liu, C. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.122301
Labrecque, C. L., Ko, A., Qiao, B., Pan, C., Nandakumar, R., Chowdhury, K., Venkatesan, N., Du, X., Cai, B., Pellegrini, M. A., et al. (2026) · Hepatology Communications · doi:10.1097/hc9.0000000000001015 · Cited by 1
Matrix stiffness shapes early transcriptional trajectories during hepatic stellate cell activation
Inada, K., Miyoshi, M., Kakinuma, S., Watakabe, K., Mochida, T., Shimizu, T., Tsuchiya, J., Nobusawa, T., Kaneko, S., Kawai‐Kitahata, F., et al. (2026) · Hepatology International · doi:10.1007/s12072-026-11141-0
Abdelhamid, A. K., Pedrini, F., Schmitt, J., Fayed, I. H., Osama, A., Rashwan, H. H., Hanna, D. M. F., Menze, E. T., Magdeldin, S., Luzarowski, M., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177847
An, P., Wu, L., & Wang, R. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119883
Liu, X., Gao, Y., Yang, J., Fu, Z., Yang, W., Sun, J., Wang, Y., Huang, R., Zheng, R., Xu, Q., et al. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119330
Wang, F., 朱克祥, Zhu, X., Yao, J., Sun, Z., & Li, X. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1966076 · Cited by 1
Gehlot, D., Bakriwala, S., & Patel, Y. D. (2026) · Annals of the National Academy of Medical Sciences (India) · doi:10.25259/anams_26_2026
Metadata
- Authors
- Mannaerts, I., Leite, S. B., Verhulst, S., Claerhout, S., Eysackers, N., Thoen, L. F. R., Hoorens, A., Reynaert, H., Halder, G., & van Grunsven, L. A.
- Affiliations
- Vrije Universiteit Brussel (BE)
- KU Leuven (BE)
- Universitair Ziekenhuis Brussel (BE)
- Corresponding author
- van Grunsven, Leo A.
- ORCID
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 63
- Issue
- 3
- Pages
- 679-688
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2154530183
- Cited by
- 410
- References
- 46
- Citations by year
- 2026: 37 · 2025: 44 · 2024: 43 · 2023: 29 · 2022: 60 · 2021: 49 · 2020: 35 · 2019: 38 · 2018: 29 · 2017: 23 · 2016: 19 · 2015: 4
- FWCI
- 14.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- YAP, Hippo signaling pathway, hepatic stellate cell activation, liver fibrosis, YAP inhibition, carbon tetrachloride-induced liver injury, nuclear translocation, transcriptional coactivator, liver cirrhosis, fibrogenesis
- MeSH terms
- Hippo Signaling Pathway, YAP-Signaling Proteins, Animals, Humans, Liver Cirrhosis, Mice, Inbred BALB C, Phosphoproteins, Transcription Factors, Signal Transduction, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Adaptor Proteins, Signal Transducing, Mice, Hepatic Stellate Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
